Evidence map›Paper›PMID 32760671›Full record

ArticleFrontiers in oncology2020

The Influence of Pre-Existing Beta-Blockers Use on Survival Outcomes in HER2 Positive Advanced Breast Cancer: Pooled Analysis of Clinical Trial Data.

Natansh D Modi, Jin Quan Eugene Tan, Andrew Rowland, Bogda Koczwara, Ganessan Kichenadasse, Ross A McKinnon, Michael D Wiese, Michael J Sorich, Ashley M Hopkins

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Natansh D ModiCollege of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Jin Quan Eugene TanCollege of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Andrew RowlandCollege of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Bogda KoczwaraCollege of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Ganessan KichenadasseCollege of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Ross A McKinnonCollege of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Michael D WieseSchool of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia.
Michael J SorichCollege of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Ashley M HopkinsCollege of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

beta-blockersbreast cancerHER2 positivesurvivaltargeted therapy

Identifiers

PMID32760671
PMCPMC7373122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.